Interest of antioxidants in the care of the patients infected by the HIV: The experience of long term administration of Alternanthera pungens herb tea;Intérêt des antioxydants dans la prise en charge des patients infectés par le VIH: Apport de la consommation régulière de tisane d'Alternanthera pungens

Annales de Biologie Clinique

Volumn 67, Issue 5, 2009, Pages 563-568

  Djohan, Y F ^a   Camara, C ^a   Monde A A ^a   Koffi, G ^b   Niamk e G ^b   Dere L ^c   Tiahou, G ^c   Djessou, P ^b   Sess, D ^a  

^a CHU de Cocody   (Côte d’Ivoire)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c Université Alassane Ouattara   (Côte d’Ivoire)

Author keywords

Alternanthera pungens; Antioxidants; Care; Ivory coast

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; MALONALDEHYDE;

AMARANTHACEAE; ARTICLE; BEVERAGE; BLOOD; CD4 CD8 RATIO; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYTOTHERAPY; PROSPECTIVE STUDY;

AMARANTHACEAE; BEVERAGES; BIOLOGICAL MARKERS; CD4-CD8 RATIO; GLYCOSYLATION END PRODUCTS, ADVANCED; HIV INFECTIONS; HUMANS; MALONDIALDEHYDE; PHYTOTHERAPY; PROSPECTIVE STUDIES;

ALTERNANTHERA PUNGENS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 73949130805     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2009.0362     Document Type: Article

References (25)

1. Barry H. Free radicals, antioxidant and human diseases: curiosity, cause or consequence. Lancet 1994; 334: 721-4.
2. Favier A. Stress oxydant: intérêt de sa mise en évidence en biologie médicale et problèmes posés par le choix d'un marqueur. Ann Biol Clin 1997; 55: 9-16.
3. Flourié F, Arab K, Gagnieu MC, Tardy JC, Jeanblanc F, Livrozet JM. Statut oxydatif de patients VIH positifs sous trithérapie. Ann Biol Clin 2004; 62: 713-5.
4. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990; 85: 47-54.
5. Montagnier L. Stress oxydant et SIDA. Rev Addict 2004; 6: 1064-6.
6. de Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, et al. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 2000; 30: 915-29.
7. Price TO, Recall N, Akanke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Research 2005; 1045: 57-63.
8. OMS. Traditional medicine programme and global programme on AIDS. Report of a WHO consultation on traditional medicine and aids: Clinical evaluation of traditional medicines and natural products. Genève, 26-28 septembre 1990 WHO/TRM/GPA/90.2.
9. Bodeker G, Kabatesi D, King R, Homsy J. A regional task force on traditional medicine and AIDS. Lancet 2000; 355: 1284.
10. Adjanohoun E, Aké A. Contribution au recensement des plantes médicales de Côte d'Ivoire. Centre National de Floristique, Abidjan 1979, 358 p.
11. Zirihi GN, Kra A, Bahi C, Guédé G. Plantes médicinales immunostimulantes. Critères de sélection, techniques rapides d'extraction des principes actifs et méthodes d'évaluation de l'activité immunogène. Rev Med Pharm Afr 2003; 17: 131-8.
12. Aké AI. Médecine traditionnelle et pharmacopée. Rapport sur le colloque international sur la médecine traditionnelle africaine. Abidjan - Côte d'Ivoire. Médecine traditionnelle et pharmacopée 1991; 4: 203.
13. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipid 1987; 45: 337-51.
14. Witko-Sarasat V, Friedlander M, Capeillere-Blandin C, Nguyen- Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein end products as novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-13.
15. Truong TXL, Luong TT, Scott-Algara D. CD4+ cell and CD8+ cellmediated resistance to HIV-1 infection in exposed uninfected intravascolar drug users in Vietnam. AIDS 2003; 182: 1365-74.
16. Mattson MP, Haughey NJ, Nath A. Cell death in HIV dementia. Cell Death Differ 2005; 12: 893-904.
17. Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D. Oxidative stress and neuro AIDS: triggers, modulators and novel antioxidants. Trends Neurosci 2001; 24: 411-6.
18. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. Programmed death of T cells in HIV 1 infection. Science 1992; 257: 217-20.
19. Klein JA, Ackerman SL. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 2003; 111: 785-93.
20. Gougeon ML, Olivier R, Garcia S, Guetard D, Dragic T, Dauguet C. Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients. CR Acad Sci 1991; 312: 529-37.
21. Valcour V, Shiramizu B. HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. Mitochondrion 2004; 4: 119-29.
22. Pocernich CB, Sultana R, Mohmmad-Abdul H, Nath A, Butterfield DA. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Research 2005; 50: 14-26.
23. Zirihi GN, Datte YJ, Guede G. Activité immunostimulante et antivirale de l'extrait aqueux d'Altenanthera pungens. Rev Med Pharm Afr 2001; 15: 59-67.
24. Sabin CA, Smith CJ, Youle M. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS 2006; 20: 67-71.
25. May M, Porter K, Sterne J, Royston P, Egger M. Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. J Clin Epidemiol 2005; 58: 1033-41.